EUA
LumiraDx SARS-CoV-2 Ab Test
FDA Emergency Use Authorization · LumiraDx UK Ltd. · Aug 31, 2022
Key facts
| Product | LumiraDx SARS-CoV-2 Ab Test |
|---|---|
| Company | LumiraDx UK Ltd. |
| Product type | Total Antibody, Fluorescence Immunoassay, Fingerstick Whole Blood |
| Date | Aug 31, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: